Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation (Q33405812)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation |
scientific article |
Statements
1 reference
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation (English)
1 reference
Rossella Paolini
1 reference
Francesco Rodeghiero
1 reference
Carlo Visco
1 reference
Silvia Finotto
1 reference
Renato Zambello
1 reference
Andrea Menin
1 reference
Roberta Zanotti
1 reference
Francesco Zaja
1 reference
Giovanni Pizzolo
1 reference
Emanuele S G D'Amore
1 reference
11 February 2013
1 reference
1 reference
Identifiers
1 reference